Six months after initiation of SIT , we recorded a reduction in cell surface CD@L expression in the CD@ + T-cell population and a shift in the cytokine production profile ( decrease in IL-@-producing CD@ + T cells and increase in IFN-gamma , IL-@ , and TGF-beta@ ) .